Lista de obras -

A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)

artículo científico publicado en 2009

A fully automated method for quantifying and localizing white matter hyperintensities on MR images

artículo científico publicado en 2006

A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures

artículo científico publicado en 2013

Achieving long-term optimal outcomes in geriatric depression and anxiety.

artículo científico publicado en 2003

An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients

artículo científico publicado en 2008

Apathy after hip fracture: a potential target for intervention to improve functional outcomes

artículo científico publicado en 2009

Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients

artículo científico publicado en 2009

Brain imaging findings predict blood pressure response to pharmacological treatment

artículo científico publicado en 2008

Brief report of affective state and depression status after traumatic brain injury.

artículo científico publicado en 2014

CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly

artículo científico publicado en 2006

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression

artículo científico publicado en 2006

Cognitive Impairments and Depressive Symptoms Did Not Impede Upper Limb Recovery in a Clinical Repetitive Task Practice Program After Stroke ⬇️

artículo científico publicado el 1 de abril de 2012

Cognitive and Behavioral Correlates of Low Vitamin B12 Levels in Elderly Patients With Progressive Dementia

article

Cognitive and affective predictors of rehabilitation participation after stroke.

artículo científico publicado en 2010

Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia.

artículo científico publicado en 2002

Cognitive impairment in acquired brain injury: a predictor of rehabilitation outcomes and an opportunity for novel interventions.

artículo científico publicado en 2011

Depression after stroke: a prospective epidemiological study

artículo científico publicado en 2004

Depression in late-life: shifting the paradigm from treatment to prevention

artículo científico publicado en 2006

Depression treatment for patients with complex conditions

artículo científico publicado en 2012

Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old

artículo científico publicado en 2008

Developing complex interventions: lessons learned from a pilot study examining strategy training in acute stroke rehabilitation

artículo científico publicado en 2013

Differential cortical atrophy in subgroups of mild cognitive impairment.

artículo científico publicado en 2005

Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study

artículo científico publicado en 2014

Do clinical rehabilitation education programs really improve stroke-related knowledge?

artículo científico publicado en 2008

Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features?

artículo científico publicado en 2008

Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial

artículo científico publicado en 2019

Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study

scientific article published on 15 November 2020

Effect of age on the frequency of anxiety disorders in major depression with psychotic features

artículo científico publicado en 2010

Effect of cerebrovascular risk factors on depression treatment outcome in later life

artículo científico publicado en 2002

Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial

artículo científico publicado en 2013

Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial

artículo científico publicado en 2020

Empirically derived decision trees for the treatment of late-life depression

artículo científico publicado en 2008

Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).

artículo científico publicado en 2015

Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression

artículo científico publicado en 2012

Feasibility of a Cognitive Behavioral Intervention to Manage Fatigue in Individuals With Traumatic Brain Injury: A Pilot Study

artículo científico publicado en 2015

Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors

artículo científico publicado en 2004

Guided Training Relative to Direct Skill Training for Individuals With Cognitive Impairments After Stroke: A Pilot Randomized Trial

artículo científico publicado en 2016

Health-related quality of life in remitted psychotic depression✰

scientific article published on 28 May 2019

Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial

artículo científico publicado en 2011

Impact of prior treatment exposure on response to antidepressant treatment in late life

artículo científico publicado en 2006

Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for Psychotic Depression (STOP-PD study).

artículo científico

Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression

artículo científico publicado en 2017

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

artículo científico publicado en 2011

Maintenance treatment of major depression in old age

artículo científico publicado en 2006

Measuring psychotic depression

artículo científico publicado en 2013

Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account

scientific article published on 02 January 2014

Medical burden in late-life bipolar and major depressive disorders

artículo científico publicado en 2008

Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study

artículo científico publicado en 2011

Missed diagnosis of psychotic depression at 4 academic medical centers

artículo científico

Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression

artículo científico publicado en 2007

Overcoming practical challenges to conducting clinical research in the inpatient stroke rehabilitation setting

artículo científico publicado en 2015

Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features

artículo científico

Pilot feasibility of an mHealth system for conducting ecological momentary assessment of mood-related symptoms following traumatic brain injury.

artículo científico publicado en 2015

Post stroke depression: epidemiology, pathophysiology, and biological treatment

artículo científico publicado en 2002

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

artículo científico publicado en 2007

Preventing depression after stroke

artículo científico publicado en 2006

Preventing depression in medical illness: a new lead?

artículo científico publicado en 2007

Psychiatric Diagnoses Among Older Recipients of Publicly Funded Mental Health Services

artículo científico publicado en 2017

Rating scales measuring the severity of psychotic depression

artículo científico publicado en 2015

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy

artículo científico publicado en 2007

Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression

artículo científico publicado en 2015

Reliability and validity of the Executive Interview (EXIT) and Quick EXIT among community dwelling older adults

artículo científico publicado en 2013

Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability

artículo científico publicado en 2008

Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study

artículo científico publicado en 2018

SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study

artículo científico publicado en 2016

Stabilization treatment of remitted psychotic depression: the STOP-PD study

artículo científico publicado en 2018

Strategy Training During Inpatient Rehabilitation May Prevent Apathy Symptoms After Acute Stroke

artículo científico publicado en 2015

Strategy Training Shows Promise for Addressing Disability in the First 6 Months After Stroke.

artículo científico publicado en 2014

Stroke-related knowledge and health behaviors among poststroke patients in inpatient rehabilitation

scientific article published on 01 September 2007

Structural brain networks in remitted psychotic depression

artículo científico publicado en 2020

Subsyndromal depression and anxiety in older adults: Health related, functional, cognitive and diagnostic implications ⬇️

artículo científico publicado el 13 de febrero de 2013

Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II

artículo científico publicado en 2013

The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression

artículo científico

The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.

artículo científico publicado en 2015

The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

article

The feasibility of meta-cognitive strategy training in acute inpatient stroke rehabilitation: case report

artículo científico publicado en 2011

The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression

artículo científico publicado en 2013

The relation of white matter hyperintensities to cognitive performance in the normal old: education matters.

artículo científico publicado en 2006

Time course of response to antidepressants in late-life major depression: therapeutic implications

artículo científico publicado en 2004

Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management

artículo científico publicado en 2010

Treatment of late-life depression alleviates caregiver burden

artículo científico publicado en 2009

Lista de obras de

A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)

A fully automated method for quantifying and localizing white matter hyperintensities on MR images

A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures

Achieving long-term optimal outcomes in geriatric depression and anxiety.

An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients

Apathy after hip fracture: a potential target for intervention to improve functional outcomes

Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients

Brain imaging findings predict blood pressure response to pharmacological treatment

Brief report of affective state and depression status after traumatic brain injury.

CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression

Cognitive Impairments and Depressive Symptoms Did Not Impede Upper Limb Recovery in a Clinical Repetitive Task Practice Program After Stroke ⬇️

Cognitive and Behavioral Correlates of Low Vitamin B12 Levels in Elderly Patients With Progressive Dementia

Cognitive and affective predictors of rehabilitation participation after stroke.

Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia.

Cognitive impairment in acquired brain injury: a predictor of rehabilitation outcomes and an opportunity for novel interventions.

Depression after stroke: a prospective epidemiological study

Depression in late-life: shifting the paradigm from treatment to prevention

Depression treatment for patients with complex conditions

Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old

Developing complex interventions: lessons learned from a pilot study examining strategy training in acute stroke rehabilitation

Differential cortical atrophy in subgroups of mild cognitive impairment.

Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study

Do clinical rehabilitation education programs really improve stroke-related knowledge?

Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features?

Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial

Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study

Effect of age on the frequency of anxiety disorders in major depression with psychotic features

Effect of cerebrovascular risk factors on depression treatment outcome in later life

Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial

Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial

Empirically derived decision trees for the treatment of late-life depression

Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).

Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression

Feasibility of a Cognitive Behavioral Intervention to Manage Fatigue in Individuals With Traumatic Brain Injury: A Pilot Study

Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors

Guided Training Relative to Direct Skill Training for Individuals With Cognitive Impairments After Stroke: A Pilot Randomized Trial

Health-related quality of life in remitted psychotic depression✰

Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial

Impact of prior treatment exposure on response to antidepressant treatment in late life

Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for Psychotic Depression (STOP-PD study).

Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

Maintenance treatment of major depression in old age

Measuring psychotic depression

Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account

Medical burden in late-life bipolar and major depressive disorders

Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study

Missed diagnosis of psychotic depression at 4 academic medical centers

Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression

Overcoming practical challenges to conducting clinical research in the inpatient stroke rehabilitation setting

Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features

Pilot feasibility of an mHealth system for conducting ecological momentary assessment of mood-related symptoms following traumatic brain injury.

Post stroke depression: epidemiology, pathophysiology, and biological treatment

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

Preventing depression after stroke

Preventing depression in medical illness: a new lead?

Psychiatric Diagnoses Among Older Recipients of Publicly Funded Mental Health Services

Rating scales measuring the severity of psychotic depression

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy

Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression

Reliability and validity of the Executive Interview (EXIT) and Quick EXIT among community dwelling older adults

Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability

Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study

SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study

Stabilization treatment of remitted psychotic depression: the STOP-PD study

Strategy Training During Inpatient Rehabilitation May Prevent Apathy Symptoms After Acute Stroke

Strategy Training Shows Promise for Addressing Disability in the First 6 Months After Stroke.

Stroke-related knowledge and health behaviors among poststroke patients in inpatient rehabilitation

Structural brain networks in remitted psychotic depression

Subsyndromal depression and anxiety in older adults: Health related, functional, cognitive and diagnostic implications ⬇️

Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II

The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression

The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.

The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

The feasibility of meta-cognitive strategy training in acute inpatient stroke rehabilitation: case report

The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression

The relation of white matter hyperintensities to cognitive performance in the normal old: education matters.

Time course of response to antidepressants in late-life major depression: therapeutic implications